About
Miraecellbio develops advanced cell therapy products using allogeneic embryonic stem cell-derived mesenchymal stem cells (MMSC) to treat incurable urinary, neurological, autoimmune dermal, and musculoskeletal diseases.
Explore Miraecellbio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.